Guyasuta Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58M Buy
115,679
+911
+0.8% +$437K 3% 9
2026
Q1
$56.4M Buy
114,768
+770
+0.7% +$418K 3.26% 7
2025
Q4
$66.1M Buy
113,998
+2,559
+2% +$1.45M 3.77% 7
2025
Q3
$54.1M Buy
111,439
+1,524
+1% +$709K 3.11% 8
2025
Q2
$44.6M Buy
109,915
+5,836
+6% +$2.44M 2.73% 9
2025
Q1
$51.8M Sell
104,079
-1,585
-2% -$858K 3.39% 7
2024
Q4
$55M Buy
105,664
+1,821
+2% +$1M 3.46% 7
2024
Q3
$64.2M Buy
103,843
+1,026
+1% +$607K 3.96% 6
2024
Q2
$54.6M Sell
102,817
-2,075
-2% -$1.19M 4.01% 5
2024
Q1
$55.7M Sell
104,892
-591
-0.6% -$332K 4.04% 5
2023
Q4
$56M Buy
105,483
+820
+0.8% +$397K 4.05% 5
2023
Q3
$53M Buy
104,663
+291
+0.3% +$155K 4.1% 4
2023
Q2
$54.5M Sell
104,372
-725
-0.7% -$391K 4.03% 4
2023
Q1
$60.6M Sell
105,097
-768
-0.7% -$433K 4.68% 2
2022
Q4
$58.3M Buy
105,865
+778
+0.7% +$412K 4.6% 2
2022
Q3
$53.3M Buy
105,087
+197
+0.2% +$110K 4.61% 3
2022
Q2
$57M Buy
104,890
+582
+0.6% +$320K 4.46% 2
2022
Q1
$61.6M Sell
104,308
-156
-0.1% -$89.6K 4.23% 2
2021
Q4
$69.7M Sell
104,464
-866
-0.8% -$541K 4.57% 2
2021
Q3
$60.2M Sell
105,330
-471
-0.4% -$259K 4.29% 2
2021
Q2
$53.4M Buy
105,801
+1,082
+1% +$511K 3.84% 3
2021
Q1
$47.8M Sell
104,719
-2,119
-2% -$1.01M 3.73% 3
2020
Q4
$49.8M Sell
106,838
-5,986
-5% -$2.81M 4.16% 3
2020
Q3
$49.8M Sell
112,824
-3,706
-3% -$1.53M 4.63% 3
2020
Q2
$42.2M Sell
116,530
-522
-0.4% -$175K 4.33% 3
2020
Q1
$33.2M Sell
117,052
-1,154
-1% -$364K 3.98% 4
2019
Q4
$38.4M Sell
118,206
-1,533
-1% -$465K 3.73% 4
2019
Q3
$34.9M Buy
119,739
+303
+0.3% +$86.8K 3.61% 6
2019
Q2
$35.1M Buy
119,436
+2,132
+2% +$587K 3.64% 5
2019
Q1
$32.1M Sell
117,304
-1,859
-2% -$463K 3.58% 7
2018
Q4
$26.7M Buy
119,163
+1,429
+1% +$335K 3.29% 7
2018
Q3
$28.7M Sell
117,734
-1,577
-1% -$363K 3.06% 8
2018
Q2
$24.7M Sell
119,311
-593
-0.5% -$126K 2.83% 12
2018
Q1
$24.8M Sell
119,904
-2,764
-2% -$580K 2.9% 11
2017
Q4
$23.3M Sell
122,668
-432
-0.4% -$82.8K 2.64% 13
2017
Q3
$23.3M Sell
123,100
-1,102
-0.9% -$200K 2.81% 12
2017
Q2
$21.7M Sell
124,202
-971
-0.8% -$163K 2.61% 15
2017
Q1
$19.2M Buy
125,173
+1,110
+0.9% +$170K 2.32% 20
2016
Q4
$17.5M Buy
124,063
+4,036
+3% +$595K 2.26% 20
2016
Q3
$19.1M Buy
120,027
+2,529
+2% +$390K 2.44% 18
2016
Q2
$17.4M Buy
117,498
+521
+0.4% +$76.9K 2.32% 20
2016
Q1
$16.6M Buy
116,977
+14,915
+15% +$2M 2.3% 21
2015
Q4
$14.5M Buy
102,062
+1,098
+1% +$146K 2.04% 23
2015
Q3
$12.3M Buy
100,964
+486
+0.5% +$63.3K 1.8% 27
2015
Q2
$13M Buy
100,478
+1,285
+1% +$168K 1.73% 27
2015
Q1
$13.3M Buy
+99,193
New +$12.8M 1.79% 27

Other funds holding TMO

Guyasuta Investment Advisors's TMO Position: Q2 2026 in Review

Guyasuta Investment Advisors increased its Thermo Fisher Scientific (TMO) stake by 0.79% in Q2 2026, buying an estimated $437K and bringing the position to 115,679 shares worth $58M. The position accounts for 3% of the portfolio, ranked #9.

Guyasuta Investment Advisors first reported a position in TMO in Q1 2015 and has held it in 46 quarters since. The position peaked at $69.7M in Q4 2021. 1,118 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Guyasuta Investment Advisors held 115,679 shares of Thermo Fisher Scientific worth $58M as of Q2 2026.
  • Guyasuta Investment Advisors bought 911 Thermo Fisher Scientific shares in Q2 2026, an estimated $437K.
  • Thermo Fisher Scientific made up 3% of Guyasuta Investment Advisors's portfolio in Q2 2026, its #9 holding.
  • Guyasuta Investment Advisors first reported a position in Thermo Fisher Scientific in Q1 2015 and has held it in 46 quarters since.
  • Guyasuta Investment Advisors's Thermo Fisher Scientific position peaked at $69.7M in Q4 2021.
  • 1,118 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Guyasuta Investment Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.